To include your compound in the COVID-19 Resource Center, submit it here.

Dor BioPharma, University of Texas deal

DOR licensed exclusive option rights to IP

Read the full 71 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE